Explore how the innovative combination of ThymoQuin™ and Omega-3 can combat obesity-induced health issues. In the study “Cold-Pressed Nigella Sativa Oil Standardized to 3% Thymoquinone Potentiates Omega-3 Protection against Obesity-Induced Oxidative Stress, Inflammation, and Markers of Insulin Resistance Accompanied with Conversion of White to Beige Fat in Mice,” researchers from Cornell Medicine, NY Medical College, Brooklyn Methodist Hospital, and The Edwards School of Medicine examined the effects of ThymoQuin™ and Omega-3 on obesity-related inflammation and insulin resistance. This groundbreaking research highlights the potential of ThymoQuin™, a patented black seed oil with 3% thymoquinone and less than 2% free fatty acids, in combination with Omega-3 to significantly improve health markers.
Study at a Glance:
- Purpose: Investigate the effects of ThymoQuin™ (3% thymoquinone, <2% free fatty acids) and Omega-3 on obesity-related health issues
- Key Findings:
- Reduced lipid droplet size and increased markers of beige adipocytes (healthy fat)
- Decreased levels of inflammatory adipokines and markers of insulin resistance
- Enhanced mitochondrial biogenesis and energy metabolism
- Improved insulin sensitivity and reduced chronic inflammation
These findings underscore the remarkable benefits of ThymoQuin™ when combined with Omega-3. By promoting the conversion of unhealthy white fat to beneficial beige fat, this powerful duo helps reduce inflammation and improve insulin sensitivity, tackling obesity-related health problems from multiple angles. Dive into the full study to learn more about how ThymoQuin™ and Omega-3 can revolutionize your approach to weight management and overall health.
Read the full study here
